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S U M M A R Y
Objective: To deﬁne the impact of helminthic infestations and their treatment on viral load and T cell
subsets in chronic HIV-1-infected patients.
Methods: Two hundred twenty chronic HIV-1-infected Ethiopian patients with (N = 87) and without
(N = 133) helminthic infestations were included. To determine the impact of deworming on viral load
and T cell subsets, a subset of these patients with (n = 23) and without (n = 20) helminthic infestations
were followed longitudinally. Helminth egg loads, plasma HIV RNA levels, and peripheral blood CD4+ and
CD8+ T cells were determined at baseline and at 12 weeks after antihelminthic treatment.
Results: At baseline, plasma viral load was signiﬁcantly higher in individuals with (n = 87) than without
(n = 133) a helminthic infestation (5.01 log10 vs. 3.41 log10, p < 0.001). Twelve weeks after antihelminthic
treatment, plasma HIV RNA levels were reduced in the successfully treated group (p < 0.001). Twelve
weeks after antihelminthic treatment, helminth infestations and their treatment had no signiﬁcant
effect on CD4+ T cell counts. However, helminth-infested individuals had a higher level of CD8+ T cells at
baseline (p < 0.001), which was signiﬁcantly reduced (p < 0.01) at 12 weeks after antihelminthic
treatment.
Conclusions: Helminths were found to be associated with an increased HIV RNA level. Successful
treatment of intestinal helminths reduced plasma HIV RNA levels in chronic HIV-1 subtype C infection.
Considering the high endemicity of helminths in tropical settings, the management of chronically HIV-
infected individuals must include deworming.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Contents lists available at SciVerse ScienceDirect
International Journal of Infectious Diseases
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Since the beginning of the HIV/AIDS epidemic in 1981, nearly 30
million people have died of AIDS-related causes,1 and today, three
decades later, the virus has spread throughout the world. There are
approximately 34 million people living with HIV/AIDS. However, in
the last decade, global efforts to address this epidemic have shown
some success and there are signs that the epidemic may be
changing course. Among others, the number of people with HIV
receiving treatment in resource-poor countries has increased more
than 26-fold since 2003, reaching eight million in 2011 (54%
antiretroviral therapy (ART) coverage in the region). This has
averted a total of 2.5 million deaths. Nevertheless, Sub-Saharan
Africa bears a disproportionate burden of the HIV epidemic. It is
reported by the World Health Organization (WHO) that 69.1% of
people living with HIV reside in this region. Co-infection with other* Corresponding author. Tel.: +49 341 9714302; fax: +49 341 9714309.
E-mail address: andargachewmulu.meharie@medizin.uni-leipzig.de (A. Mulu).
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http://dx.doi.org/10.1016/j.ijid.2013.03.022pathogens like helminths, malaria, and tuberculosis, which are still
rampant in the region,2 may accelerate the transmission and
pathogenesis of HIV by enhancing viral replication.
It is well documented that helminths have a profound effect on
the host immune system and that these effects may spill over to
impact on immune responses to other pathogens3,4 by inducing
dominant type 2 response proﬁles, which inhibit the type 1
response proﬁle needed to combat and control viral antigens such
as HIV.5 Accordingly, it has been hypothesized that the chronic
immune activation and the presence of a dominant Th2 cytokine
environment may increase the risk of acquiring HIV infection6 and
increase the plasma HIV RNA level.7,8 However, the impact of
intestinal helminths and their treatment on the HIV viral load and
T cell count among asymptomatic HIV-infected individuals
remains controversial. For example, a signiﬁcant association
between helminth intensity and plasma HIV viral load, with a
signiﬁcant decrease in HIV-1 viral load following deworming, has
been reported.8 Moreover, eradication of Ascaris lumbricoides from
asymptomatic HIV-1-infected subjects resulted in a signiﬁcant
elevation in CD4+ T cell counts and a trend towards a plasma HIV-1ses. Published by Elsevier Ltd. All rights reserved.
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results of several other studies do not support the above
evidence.10–12 Data on the role of helminth infestations and their
treatment in chronic HIV infection are lacking. The purpose of the
current study was therefore to examine the impact of helminthic
infestations and their treatment on the HIV-1 plasma RNA level
and T cell count during chronic HIV infection.
2. Methods
2.1. Study design and patients
A prospective observational study was conducted to investigate
the effect of helminth infestations and their treatment on plasma
HIV-1 RNA levels and T cell counts at the University of Gondar
teaching hospital, in the north-west of Ethiopia, from April to
October 2008. HIV-infected persons over 18 years of age, with/
without advanced HIV disease, seeking treatment and willing to
participate, were evaluated using a standardized form at enrol-
ment. Ethical clearance was obtained from the Ethics Committee of
the University of Gondar and informed consent was obtained from
all study subjects. The WHO criteria for AIDS-deﬁning conditions
were used.13 Patients were excluded for the following reasons or
conditions: pregnancy, treatment with single-dose nevirapine for
prevention of mother-to-child transmission of HIV or any other
ART, known diabetes, hypertension, epilepsy, liver, cardiac, and
renal diseases, genital ulcers, or active tuberculosis at enrolment.
In total, 220 consecutive HIV-1-infected treatment-naı¨ve individ-
uals with advanced HIV disease (WHO clinical stages 3 and 4)13
were enrolled and screened for intestinal parasites. Patients who
started ART at enrolment (n = 130) or during the follow-up period
(n = 43) were excluded (Figure 1). Patients at WHO clinical stage 4,
irrespective of their CD4+ T cell count, those at WHO clinical stage 3220 known HIV
treatment-naïve in
HIV/AIDS cli
87 positive for intestinal 
parasites 
 
 
49 eligible for ART at 
enrolment  
 
25 completed the follow-up 
 
23 successfully 
treated with 
antihelminthic  
2 persistently 
positive or 
reinfected   
13 started ART during 
the follow-up  
Figure 1. Flow chart of HIV-1-infected individuals with anwith a CD4+ T cell count 350 cells/mm3, and patients with a CD4+
T cell count 200 cells/mm3 at any WHO clinical stage, were
eligible for ART.
2.2. Stool examination
Fresh stool samples collected at enrolment and at 12 weeks
after antihelminthic treatment were examined by direct micros-
copy technique using normal saline and iodine (to identify
trophozoites and cysts of protozoan parasites) and by formalin–
ether sedimentation and Kato–Katz concentration methods (to
detect helminth eggs and larvae). Coarse quantiﬁcation of
helminth eggs (expressed as eggs per gram of feces) was carried
out in accordance with the Kato–Katz technique and a scoring
system (light, moderate, and heavy infection) was adopted from
the WHO recommendations.14 Antihelminthic treatment was
given to all study participants with an intestinal parasite
infestation: 400 mg albendazole once for those with A. lumbri-
coides, Trichuris trichiura, and hookworm; 200 mg albendazole
twice daily for 3 consecutive days for those with Strongyloides
stercoralis; and 40 mg/kg praziquantel for those with Schistosoma
mansoni). Albendazole 400 mg once was also given to all
individuals without evidence of a helminth infestation, as there
might be false-negative results and to control its effect (if any).
2.3. T cell count
Venous blood (5 ml) was collected in vacutainer tubes contain-
ing ethylenediaminetetraacetic acid (EDTA) at enrolment and at 12
weeks after antihelminthic treatment for T cell subset counts and
plasma HIV RNA viral load determination. T cell counts were done
using a ﬂow cytometer (FACSCount system; Becton Dickinson, San
Jose, CA, USA) following the manufacturer’s protocol.-1-infected 
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Figure 2. Changes in plasma HIV RNA levels and CD4+ and CD8+ T cell counts in
patients with and without helminths before and after antihelminthic treatment
(HIV RNA level in log10 copies/ml and T cells in number/mm
3).
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The plasma HIV-1 RNA level was determined by quantitative
real-time PCR (Abbott m2000rt instrument, Abbott Molecular, Des
Plaines, IL, USA). The lower detection limit of the assay was 40
copies/ml (1.6 log10 RNA copies/ml). HIV-1 genotyping was
undertaken following an in-house protocol (Mulu et al., 2012,
submitted for publication). Brieﬂy, a set of nested primers was
used for ampliﬁcation of the protease and reverse transcriptase
region of the HIV-1 genome and sequencing was carried out using
an ABI Prism 310 (Applied Biosystems, Foster City, CA, USA).
2.5. Statistical analysis
The data were analyzed using SPSS software version 17.
Baseline characteristics of the individuals with helminth infesta-
tions (N = 87) and those without (N = 133) were compared using
the Student’s t-test. Egg counts and plasma HIV RNA levels were
log10-transformed for normalizing dispersed values. Changes in
plasma HIV RNA levels and T cell counts at baseline and at 12
weeks after antihelminthic treatment were compared by paired t-
test in successfully dewormed patients (n = 23) and in patients who
were persistently negative for helminths (n = 20). A p-value of
<0.05 was considered statistically signiﬁcant.
3. Results
3.1. Baseline characteristics of the subjects
Two hundred twenty chronically HIV-1-infected individuals
were screened for intestinal parasites (92 male and 128 female).
The rate of helminth infestation among males and females was not
signiﬁcantly different (45% vs. 35%). There was no signiﬁcant
difference in age among females and males, and in the prevalence
of intestinal parasites by age, sex, and other socio-demographic
variables. Eighty-seven individuals were found to be infected with
one or more intestinal parasites, making the overall prevalence of
intestinal parasites 39.5% (87/220). A. lumbricoides (24; 10.9%), T.
trichiura (14; 6.4%), hookworm (12; 5.5%), and S. mansoni (10; 4.5%)
were the most prevalent species detected. Single infestations and
multiple infestations (double and triple parasitic infestations)
were detected in 72 (32.7%) and 15 (6.8%) subjects, respectively.
3.2. Baseline differences in CD4+ and CD8+ T cell counts and plasma
HIV RNA levels
At enrolment, there was no signiﬁcant difference in CD4+ T cell
counts between helminth-infested and non-infested patients (214
vs. 212 cells/mm3, respectively). However, the mean CD8+ T cell
count was signiﬁcantly higher in those with a helminth infestation
than in those without a helminth infestation (970  113 cells/mm3
vs. 893  97 cells/mm3, p = 0.035). The mean plasma HIV viral load
was consistently and signiﬁcantly higher in individuals with lower
CD4+ T cell levels. The mean plasma HIV RNA level at baseline (n =
220) was 4.30  1.09 log10 RNA copies/ml. There were no differences
in plasma HIV RNA levels (p = 0.7) and CD4+ T cell counts (p = 0.3)
between females and males. However, plasma HIV RNA levels were
signiﬁcantly higher in individuals co-infected with intestinal para-
sites (n = 87) than in those not co-infected (n = 133) (4.83  0.9 vs.
3.95  1.1 log10 HIV RNA copies/ml, p < 0.001).
No signiﬁcant association was found between the presence of
an individual intestinal parasite and plasma HIV viral load.
Individuals infested with multiple intestinal parasite species (n
= 15) had slightly higher mean plasma HIV RNA levels than those
infested with single parasites (n = 72) (4.83  0.78 vs. 4.62  0.75
log10 RNA copies/ml, p < 0.01). No signiﬁcant association (p > 0.05)was found between helminth egg loads and plasma HIV RNA levels.
The mean baseline plasma HIV RNA level was not signiﬁcantly
different between individuals with high or moderate intensity
helminth infestations (n = 12) and in individuals with low intensity
helminth infestations (n = 48) (4.21  0.83 vs. 4.14  0.48 log10
copies/ml, p > 0.05). HIV-1 subtype C was identiﬁed in all cases (data
not shown).
In the helminth treated and responder group, similar to the
entire study group, there was no signiﬁcant difference in CD4+ T
cell count (Figure 2A) between helminth-infested and non-infested
patients (358  92 vs. 323  78 cells/mm3, respectively). However,
at baseline the CD8+ T cell count, as well as HIV viral load, was
signiﬁcantly higher in the helminth-infested group compared to the
non-infested group (1413  161 vs. 896  124 cells/mm3; 5.01 vs.
3.41 log10 copies/ml) (Figure 2B and 2C). There was no signiﬁcant
association between helminth egg load and plasma HIV RNA level
(data not shown). There were no statistically signiﬁcant changes in
CD4+ T cell counts between baseline and 12 weeks after anti-
helminthic treatment and the presence of speciﬁc parasites (Table 1).
Table 1
Helminth species-speciﬁc changes in HIV RNA levels (log10 HIV RNA in copies/ml)
and CD4+ and CD8+ T cell counts (cells/mm3) before and after deworming
Helminth Baseline After 12 weeks p-Value
Helminths successfully treated
Ascaris lumbricoides (n = 10)
Log10 HIV RNA 4.94  0.85 4.74  0.85 0.001a
CD4+ T cell count 386 365 0.070
CD8+ T cell count 1469 1073 0.001a
Hookworm (n = 6)
Log10 HIV RNA 4.94  0.69 4.75  0.67 0.038a
CD4+ T cell count 363 314 0.06
CD8+ T cell count 1108 978 0.029a
Trichuris trichiura (n = 4)
Log10 HIV RNA 5.22  0.48 4.91  0.49 0.086
CD4+ T cell count 394 366 0.69
CD8+ T cell count 1442 1361 0.051
Strongyloides stercoralis (n = 1)
Log10 HIV RNA 5.6 4.55 NA
CD4+ T cell count 347 245 NA
CD8+ T cell count 1066 931 NA
Schistosoma mansoni (n = 1)
Log10 HIV RNA 4.80 4.71 NA
CD4+ T cell count 294 237 NA
CD8+ T cell count 1344 1139 NA
Hookworm and S. stercoralis (n = 1)
Log10 HIV RNA 4.96 4.82 NA
CD4+ T cell count 363 219 NA
CD8+ T cell count 1384 1196 NA
Persistently helminth-positive
S. mansoni (n = 1)
Log10 HIV RNA 3.08 6.19 NA
CD4+ T cell count 350 321 NA
CD8+ T cell count 2000 1679 NA
S. stercoralis (n = 1)
Log10 HIV RNA 4.82 5.31 NA
CD4+ T cell count 291 236 NA
CD8+ T cell count 1744 1355 NA
NA, not applicable.
a p < 0.05.
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CD4+ and CD8+ T cell counts
The effect of helminth treatment on HIV viral load and CD4+ and
CD8+ T cell counts was assessed in 47 patients who were not on
antiretroviral drugs (25 with a helminth infestation and 22
without). Additional stool and blood samples were collected 12
weeks after antihelminthic treatment. Among the 25 individuals
with a helminth infestation, 23 were successfully treated (92%) and
only two (8%) were found to be positive for the same helminth at
the end of 12 weeks.
Twelve weeks after antihelminthic treatment, a signiﬁcant
reduction (p < 0.001) in CD8+ T cells was observed (Figure 2B) in
the treated and responder group. Interestingly, 12 weeks after
antihelminthic treatment, there was a mean decrease in plasma
HIV RNA level (0.3 log10  0.83) in the successfully treated and
responder group (5.01 vs. 4.71 log10 copies/ml; p < 0.001) (Figure 2C).
In contrast, there was a statistically signiﬁcant mean increase in
plasma HIV RNA level (+0.54 log10  0.23) in the persistently
helminth-negative group (Figure 2C). The change in plasma HIV RNA
among individuals with high (5.0 log10 copies/ml; n = 17) baseline
plasma HIV RNA was 0.25 log10 copies/ml after antihelminthic
treatment in the helminth-infested group (5.24 vs. 4.99 log10 copies/
ml; p = 0.3) and +0.02 log10 copies/ml at the same time point in the
helminth non-infested group (5.18 vs. 5.16 log10 copies/ml; p = 0.8).
The primary outcome was not different after adjusting for age, sex,
and CD4+ T cell count (data not shown). Irrespective of the type of
intestinal helminth, there was a decline in plasma HIV RNA level at 12
weeks after antihelminthic treatment. A signiﬁcant reduction inplasma HIV RNA level was observed in individuals infested with
Ascaris and hookworm (Table 1).
4. Discussion
The ﬁnding of a 0.88 log10 difference in baseline HIV viral load
between individuals with a helminth co-infection and those
without is in line with previous studies from East African
countries.8–10,15 Although a higher HIV viral load has been
reported to be associated with faster disease progression16–18 in
the context of helminthic infestations, the concept remains
controversial due to a lack of well-controlled longitudinal
studies19 and because of other potential factors that could
contribute to the increase in plasma HIV RNA level.4,20,21 A study
from Zambia showed a higher median pre-treatment plasma HIV
RNA level (0.33 log10 copies/ml) in the helminth uninfected group
compared to the helminth infested group.12 Studies from Malawi
and Uganda have reported a lack of association between helminth
infestation and faster progression of HIV disease in co-infected
individuals.11,22 Nevertheless, the higher HIV viral load among
chronically infected HIV patients with a helminth co-infection
compared to helminth uninfected patients could be due to
immune activation in the helminth infestation, resulting in a
higher level of CD8+ T cells.21,23 It has been documented that
helminth infestations alter T cell subsets and that the treatment of
helminth infestations shows a tendency to reduce the immune
activation, indicating that the treatment of helminth infestations
could be used to down-regulate the observed immune activa-
tion.23,24 Similarly, an increased CD8+ lymphocyte count and
elevated levels of activated CD8+ T cells expressing HLA-DR were
observed among Ethiopian immigrants with helminth infesta-
tions in Israel,21 suggesting that immune activation is a major
factor in increasing HIV-1 RNA levels, accounting for the increased
susceptibility and progression of HIV infection in Africa and the
developing countries.3
An impact on CD4+ T cell numbers was not detectable in
individuals with or without a helminth co-infection.8,25 The overall
observed low level of CD4+ T cell counts in the current study is in
agreement with previous reports.8,25 It has to be remembered that
irrespective of the HIV infection state, CD4+ T cell counts are lower
among Ethiopians than among people from the USA or from
Europe.23,26 The prevalence of co-infection with intestinal para-
sites among chronically infected HIV-1 subtype C patients was as
high as 39.5%, which corresponds well with previous studies from
Sub-Saharan Africa.12,15,16,27
An increase in plasma HIV RNA level among helminth
uninfected individuals within 12 weeks was observed, reﬂecting
the natural history of HIV disease progression in ART-naı¨ve
individuals.19 The signiﬁcant decline (0.3 log10) in plasma HIV
RNA levels after deworming of helminths in the infested and
responder group in this study is in line with a systematic review of
trials by Walson et al.,16 who suggested that the treatment of
helminth species may reduce the plasma HIV RNA load. Taking the
natural course of HIV infection into account, the decline in plasma
HIV viral load as a consequence of the deworming treatment in the
present study is impressive. It is consistent with the data from a
systematic review.16 Similarly, the treatment of other co-infec-
tions, e.g. malaria and sexually transmitted diseases, has long been
known to signiﬁcantly reduce the HIV viral load.28–30 In contrast to
the ﬁndings in chronic HIV, studies of asymptomatic HIV-infected
individuals did not indicate an association between treatment of
intestinal helminth infestations and a decrease in plasma HIV RNA
levels.10–12 The difference in plasma HIV RNA levels cannot be
attributed to albendazole, since individuals without evidence of a
helminth infestation received this broad-spectrum antihelminthic
drug at baseline and it did not cause a decrease in plasma HIV RNA.
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plasma HIV RNA level has previously been reported.8,9 However,
we could not ﬁnd such a correlation in our study population,
probably because of a lower burden of helminths or variable
duration of helminth infestation, which limits the excretion of
eggs.31 The lack of association of plasma HIV viral load and the
presence of speciﬁc helminths in this study are in agreement with a
previous study,8,12,15 but differ from a study conducted in Kenya
that reported a signiﬁcant association between HIV RNA level and
ascariasis.9 Why HIV was impacted by ascariasis but not by others
remains unclear. All studies discussed in this paper were
conducted on subjects with asymptomatic HIV infections. Thus,
the observed differences in the ﬁndings could also be related to
both the variation in HIV subtypes and the course of HIV infection.
In conclusion, despite its obvious limitations such as the small
sample size, the data presented here are of signiﬁcant public health
importance in areas where both HIV and helminths coexist
epidemiologically. Chronically HIV-1 subtype C infected individu-
als with helminth co-infections had a signiﬁcantly higher level of
HIV viremia compared to helminth uninfected individuals (4.83 
0.9 vs. 3.95  1.1 log10 HIV RNA copies/ml, p < 0.001) and deworming
signiﬁcantly reduced the level of plasma HIV RNA (5.01 vs. 4.71 log10
copies/ml; p < 0.001). Considering the prevalence of helminths in
tropical settings and the possible implication of HIV–helminth co-
infection, diagnosis and treatment of helminth infestations is an
important approach to contribute to delaying HIV-1 disease
progression, as has previously been suggested.
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